Lv12
29 积分 2025-01-05 加入
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials
1小时前
待确认
非奈利酮治疗2型糖尿病相关慢性肾脏病的进展及展望
3天前
已完结
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
4天前
已完结
盐皮质激素受体拮抗剂非奈利酮在2型糖尿病肾病中的作用：从分子结构到心肾保护作用机制
6天前
已完结
Finerenone Modulates PANoptosis to Improve Immune Microenvironment in Diabetic Nephropathy: A Machine Learning-Based Mechanistic Analysis
8天前
已完结
Evidence construction of Huangkui capsule against chronic glomerulonephritis: A systematic review and network pharmacology
19天前
已完结
Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease
21天前
已完结
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
22天前
已完结
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial
22天前
已完结
皖公网安备34019202002308
